Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
The Journal of Pharmacy and Pharmacology|March 1, 1981
Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strainsS G Al-Dabbagh, J R Idle, R L SmithBiochemical Pharmacology|October 15, 1982
Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strainsA Küpfer, S G Al-Dabbagh, J C Ritchie, et al.European Journal of Clinical Pharmacology|January 1, 1982
Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquineM Oram, K Wilson, D Burnett, et al.Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1984
Species differences in oxidative drug metabolism: some basic considerationsS G Al-Dabbagh, R L SmithCancer Detection and Prevention|January 1, 1989
Cytochrome P450IID phenotypes and human cancer riskJ R IdleMutation Research|April 1, 1991
Is environmental carcinogenesis modulated by host polymorphism?J R IdlePrague Medical Report|July 13, 2005
Christmas gingerbread (Lebkuchen) and Christmas cheer--review of the potential role of mood elevating amphetamine-like compounds formed in vivo and in furnoJ R IdlePharmacological Research|January 1, 1993
Antagonism of medetomidine-induced ataxia in rats by yohimbine, aminophylline and caffeineF K Mohammad, K A Dawood, S G al-DabbaghIARC Scientific Publications|January 1, 1982
Population studies of polymorphism in drug oxidation and its relevance to carcinogenesisJ C Ritchie, J R IdleJournal of Chromatography|March 13, 1992
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasmaA V Boddy, J R IdlePageof 13